Cite Filings / PRLD / 0000950170-25-035921

Feed Companies Filings Check

Sign in

10-K

Annual Report

Prelude Therapeutics Inc Filed 2025-03-10 Acc 0000950170-25-035921

Documents 1

10-K Annual Report , prld-20241231.htm

Around this filing

2026-03-10 10-K Annual Report
2025-03-14 4 CEO bought 97,500 shares at an average $0.71 ($69,564)
2025-03-10 S-8 Securities Offered to Employees in Benefit Plans
2025-03-10 10-K Annual Report
2025-03-10 8-K Results of operations · Regulation FD disclosure
2024-02-15 10-K Annual Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading prld-20241231.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…